Glauconix is a contract research company utilizing a patented platform which cuts development costs for bringing effective vision saving drugs to market faster.
Glauconix is contract research organization (CRO) serving the biopharma industry by providing an innovative service using a patented platform to accelerate glaucoma drug development. The team is comprised of key opinion leaders in the ophthalmic industry. This year-old company has generated over $600K in customer revenue. Glauconix is raising capital to grow the company and meet the demands of the world’s largest pharmaceutical companies.